Anthony Traboulsee

Head MS/NMO Programs

Website

http://ms.vchri.ca

Degrees / Designations

Email Address

t.traboulsee@ubc.ca

Phone

604.822.0788

Fax

604.822.7703

Mailing Address

University of British Columbia Hospital 2211 Wesbrook Mall, room s-113 Vancouver, BC V6T 2B5 Canada

http://ca.linkedin.com/pub/tony-traboulsee/4/441/b15/

Biography

Academic Appointment

Professor

Body Locations and Systems

Multiple Sclerosis

Diagnosis and Therapy

MRI Scans

Other Areas of Research

NMO

Clinical Trial design

Anthony Traboulsee is a Professor and Research Chair of the MS Society of Canada at the University of British Columbia in Vancouver, Canada. He is the Medical Director of the MS Clinic, Director of the MS/MRI Research Group, and Director of the MS Clinical Trials Research Group at the University of British Columbia Hospital. His research focus is on the development of practice guidelines for routine use of MRI in the management of MS, establishing advanced MRI imaging outcomes in Multiple Sclerosis, and the treatment of Neuromyelitis Optica

Current Projects

NMO
MS
MRI
Clinical Trial Design

Clinical Trials

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis (VISIONARY-MS)

Multiple Sclerosis

Long Term Safety and Efficacy Study of SAR442168 in Participants With Relapsing Multiple Sclerosis

Multiple Sclerosis

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis

Multiple Sclerosis

The Canadian Proactive Cohort Study for People Living with Multiple Sclerosis

Multiple Sclerosis

Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) (AFFINITY)

Multiple Sclerosis

A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis

Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 (EXTEND)

Multiple Sclerosis

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

Multiple Sclerosis

News and Awards

Mar 8, 2017Controversial “liberation therapy” fails to treat multiple sclerosis: UBC-Vancouver Coastal Health research

Jun 1, 2016UBC-Vancouver Coastal Health scientists find genetic cause of multiple sclerosis

Nov 21, 2015VCHRI centre recruits highest number of participants for international MS study

Feb 27, 2014New Centre for Brain Health to unite research and patient care

Nov 14, 2013Often ignored aspect of MRI proves highly useful for brain scans

Oct 17, 2013The ‘cents’ behind health research

Oct 8, 2013Study finds narrowing of veins is not unique to people with MS

Jun 25, 2013Prevalence and characteristics of aggressive MS identified

Publications

Multiple sclerosis (Houndmills, Basingstoke, England) -
Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials.
Dong J, Zhao Y, Petkau AJ, Li DK, Riddehough A, Traboulsee A
Lancet (London, England) -
Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study.
Traboulsee AL, Knox KB, Machan L, Zhao Y, Yee I, Rauscher A, Klass D, Szkup P, Otani R, Kopriva D, Lala S, Li DK, Sadovnick D
Neurology -
Magnetic resonance frequency shifts during acute MS lesion formation.
Wiggermann V, Hernández Torres E, Vavasour IM, Moore GR, Laule C, MacKay AL, Li DK, Traboulsee A, Rauscher A
Multiple sclerosis and related disorders -
Treatment of Neuromyelitis Optica: Review and Recommendations.
Kimbrough DJ, Fujihara K, Jacob A, Lana-Peixoto MA, Leite MI, Levy M, Marignier R, Nakashima I, Palace J, de Seze J, Stuve O, Tenembaum SN, Traboulsee A, Waubant E, Weinshenker BG, Wingerchuk DM,
Journal of neurology, neurosurgery, and psychiatry -
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.
Goodin DS, Traboulsee A, Knappertz V, Reder AT, Li D, Langdon D, Wolf C, Beckmann K, Konieczny A, Ebers GC,

Anthony Traboulsee

Biography

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis (VISIONARY-MS)

Long Term Safety and Efficacy Study of SAR442168 in Participants With Relapsing Multiple Sclerosis

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis

The Canadian Proactive Cohort Study for People Living with Multiple Sclerosis

Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) (AFFINITY)

A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis

A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409 (TOPAZ)

Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD

Interventional Clinical Trial for CCSVI in Multiple Sclerosis Patients

Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya (IGLOO)

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 (EXTEND)

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials.

Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study.

Magnetic resonance frequency shifts during acute MS lesion formation.

Treatment of Neuromyelitis Optica: Review and Recommendations.

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.

Search form

Anthony Traboulsee

Biography

Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials.

Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study.

Magnetic resonance frequency shifts during acute MS lesion formation.

Treatment of Neuromyelitis Optica: Review and Recommendations.

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.